1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Alzheimer Market Size Growth Rate by Drug Type: 2016 VS 2021 VS 2027 1.2.2 Cholinesterase inhibitors 1.2.3 Pipeline Drugs 1.2.4 NMDA receptor antagonist 1.3 Market by Application 1.3.1 Global Alzheimer Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Sales 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Alzheimer Market Perspective (2016-2027) 2.2 Alzheimer Growth Trends by Regions 2.2.1 Alzheimer Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Alzheimer Historic Market Share by Regions (2016-2021) 2.2.3 Alzheimer Forecasted Market Size by Regions (2022-2027) 2.3 Alzheimer Industry Dynamic 2.3.1 Alzheimer Market Trends 2.3.2 Alzheimer Market Drivers 2.3.3 Alzheimer Market Challenges 2.3.4 Alzheimer Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Alzheimer Players by Revenue 3.1.1 Global Top Alzheimer Players by Revenue (2016-2021) 3.1.2 Global Alzheimer Revenue Market Share by Players (2016-2021) 3.2 Global Alzheimer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Alzheimer Revenue 3.4 Global Alzheimer Market Concentration Ratio 3.4.1 Global Alzheimer Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Revenue in 2020 3.5 Alzheimer Key Players Head office and Area Served 3.6 Key Players Alzheimer Product Solution and Service 3.7 Date of Enter into Alzheimer Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Alzheimer Breakdown Data by Drug Type 4.1 Global Alzheimer Historic Market Size by Drug Type (2016-2021) 4.2 Global Alzheimer Forecasted Market Size by Drug Type (2022-2027) 5 Alzheimer Breakdown Data by Application 5.1 Global Alzheimer Historic Market Size by Application (2016-2021) 5.2 Global Alzheimer Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Alzheimer Market Size (2016-2027) 6.2 North America Alzheimer Market Size by Drug Type 6.2.1 North America Alzheimer Market Size by Drug Type (2016-2021) 6.2.2 North America Alzheimer Market Size by Drug Type (2022-2027) 6.2.3 North America Alzheimer Market Size by Drug Type (2016-2027) 6.3 North America Alzheimer Market Size by Application 6.3.1 North America Alzheimer Market Size by Application (2016-2021) 6.3.2 North America Alzheimer Market Size by Application (2022-2027) 6.3.3 North America Alzheimer Market Size by Application (2016-2027) 6.4 North America Alzheimer Market Size by Country 6.4.1 North America Alzheimer Market Size by Country (2016-2021) 6.4.2 North America Alzheimer Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Alzheimer Market Size (2016-2027) 7.2 Europe Alzheimer Market Size by Drug Type 7.2.1 Europe Alzheimer Market Size by Drug Type (2016-2021) 7.2.2 Europe Alzheimer Market Size by Drug Type (2022-2027) 7.2.3 Europe Alzheimer Market Size by Drug Type (2016-2027) 7.3 Europe Alzheimer Market Size by Application 7.3.1 Europe Alzheimer Market Size by Application (2016-2021) 7.3.2 Europe Alzheimer Market Size by Application (2022-2027) 7.3.3 Europe Alzheimer Market Size by Application (2016-2027) 7.4 Europe Alzheimer Market Size by Country 7.4.1 Europe Alzheimer Market Size by Country (2016-2021) 7.4.2 Europe Alzheimer Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Alzheimer Market Size (2016-2027) 8.2 Asia-Pacific Alzheimer Market Size by Drug Type 8.2.1 Asia-Pacific Alzheimer Market Size by Drug Type (2016-2021) 8.2.2 Asia-Pacific Alzheimer Market Size by Drug Type (2022-2027) 8.2.3 Asia-Pacific Alzheimer Market Size by Drug Type (2016-2027) 8.3 Asia-Pacific Alzheimer Market Size by Application 8.3.1 Asia-Pacific Alzheimer Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Alzheimer Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Alzheimer Market Size by Application (2016-2027) 8.4 Asia-Pacific Alzheimer Market Size by Region 8.4.1 Asia-Pacific Alzheimer Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Alzheimer Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Alzheimer Market Size (2016-2027) 9.2 Latin America Alzheimer Market Size by Drug Type 9.2.1 Latin America Alzheimer Market Size by Drug Type (2016-2021) 9.2.2 Latin America Alzheimer Market Size by Drug Type (2022-2027) 9.2.3 Latin America Alzheimer Market Size by Drug Type (2016-2027) 9.3 Latin America Alzheimer Market Size by Application 9.3.1 Latin America Alzheimer Market Size by Application (2016-2021) 9.3.2 Latin America Alzheimer Market Size by Application (2022-2027) 9.3.3 Latin America Alzheimer Market Size by Application (2016-2027) 9.4 Latin America Alzheimer Market Size by Country 9.4.1 Latin America Alzheimer Market Size by Country (2016-2021) 9.4.2 Latin America Alzheimer Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Alzheimer Market Size (2016-2027) 10.2 Middle East & Africa Alzheimer Market Size by Drug Type 10.2.1 Middle East & Africa Alzheimer Market Size by Drug Type (2016-2021) 10.2.2 Middle East & Africa Alzheimer Market Size by Drug Type (2022-2027) 10.2.3 Middle East & Africa Alzheimer Market Size by Drug Type (2016-2027) 10.3 Middle East & Africa Alzheimer Market Size by Application 10.3.1 Middle East & Africa Alzheimer Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Alzheimer Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Alzheimer Market Size by Application (2016-2027) 10.4 Middle East & Africa Alzheimer Market Size by Country 10.4.1 Middle East & Africa Alzheimer Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Alzheimer Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan 11.1.1 Allergan Company Details 11.1.2 Allergan Business Overview 11.1.3 Allergan Alzheimer Introduction 11.1.4 Allergan Revenue in Alzheimer Business (2016-2021) 11.1.5 Allergan Recent Development 11.2 Eisai 11.2.1 Eisai Company Details 11.2.2 Eisai Business Overview 11.2.3 Eisai Alzheimer Introduction 11.2.4 Eisai Revenue in Alzheimer Business (2016-2021) 11.2.5 Eisai Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Alzheimer Introduction 11.3.4 Novartis Revenue in Alzheimer Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Daiichi Sankyo 11.4.1 Daiichi Sankyo Company Details 11.4.2 Daiichi Sankyo Business Overview 11.4.3 Daiichi Sankyo Alzheimer Introduction 11.4.4 Daiichi Sankyo Revenue in Alzheimer Business (2016-2021) 11.4.5 Daiichi Sankyo Recent Development 11.5 Merz Pharma 11.5.1 Merz Pharma Company Details 11.5.2 Merz Pharma Business Overview 11.5.3 Merz Pharma Alzheimer Introduction 11.5.4 Merz Pharma Revenue in Alzheimer Business (2016-2021) 11.5.5 Merz Pharma Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Alzheimer Introduction 11.6.4 Pfizer Revenue in Alzheimer Business (2016-2021) 11.6.5 Pfizer Recent Development 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Details 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Alzheimer Introduction 11.7.4 Johnson & Johnson Revenue in Alzheimer Business (2016-2021) 11.7.5 Johnson & Johnson Recent Development 11.8 Lundbeck 11.8.1 Lundbeck Company Details 11.8.2 Lundbeck Business Overview 11.8.3 Lundbeck Alzheimer Introduction 11.8.4 Lundbeck Revenue in Alzheimer Business (2016-2021) 11.8.5 Lundbeck Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Alzheimer Market Size Growth Rate by Drug Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cholinesterase inhibitors Table 3. Key Players of Pipeline Drugs Table 4. Key Players of NMDA receptor antagonist Table 5. Global Alzheimer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Alzheimer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Alzheimer Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Alzheimer Market Share by Regions (2016-2021) Table 9. Global Alzheimer Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Alzheimer Market Share by Regions (2022-2027) Table 11. Alzheimer Market Trends Table 12. Alzheimer Market Drivers Table 13. Alzheimer Market Challenges Table 14. Alzheimer Market Restraints Table 15. Global Alzheimer Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Alzheimer Market Share by Players (2016-2021) Table 17. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer as of 2020) Table 18. Ranking of Global Top Alzheimer Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Alzheimer Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Alzheimer Product Solution and Service Table 22. Date of Enter into Alzheimer Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Alzheimer Market Size by Drug Type (2016-2021) (US$ Million) Table 25. Global Alzheimer Revenue Market Share by Drug Type (2016-2021) Table 26. Global Alzheimer Forecasted Market Size by Drug Type (2022-2027) (US$ Million) Table 27. Global Alzheimer Revenue Market Share by Drug Type (2022-2027) & (US$ Million) Table 28. Global Alzheimer Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Alzheimer Revenue Market Share by Application (2016-2021) Table 30. Global Alzheimer Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Alzheimer Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Alzheimer Market Size by Drug Type (2016-2021) (US$ Million) Table 33. North America Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million) Table 34. North America Alzheimer Market Size by Application (2016-2021) (US$ Million) Table 35. North America Alzheimer Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Alzheimer Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Alzheimer Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Alzheimer Market Size by Drug Type (2016-2021) (US$ Million) Table 39. Europe Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million) Table 40. Europe Alzheimer Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Alzheimer Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Alzheimer Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Alzheimer Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Alzheimer Market Size by Drug Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Alzheimer Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Alzheimer Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Alzheimer Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Alzheimer Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Alzheimer Market Size by Drug Type (2016-2021) (US$ Million) Table 51. Latin America Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million) Table 52. Latin America Alzheimer Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Alzheimer Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Alzheimer Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Alzheimer Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Alzheimer Market Size by Drug Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Alzheimer Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Alzheimer Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Alzheimer Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Alzheimer Market Size by Country (2022-2027) & (US$ Million) Table 62. Allergan Company Details Table 63. Allergan Business Overview Table 64. Allergan Alzheimer Product Table 65. Allergan Revenue in Alzheimer Business (2016-2021) & (US$ Million) Table 66. Allergan Recent Development Table 67. Eisai Company Details Table 68. Eisai Business Overview Table 69. Eisai Alzheimer Product Table 70. Eisai Revenue in Alzheimer Business (2016-2021) & (US$ Million) Table 71. Eisai Recent Development Table 72. Novartis Company Details Table 73. Novartis Business Overview Table 74. Novartis Alzheimer Product Table 75. Novartis Revenue in Alzheimer Business (2016-2021) & (US$ Million) Table 76. Novartis Recent Development Table 77. Daiichi Sankyo Company Details Table 78. Daiichi Sankyo Business Overview Table 79. Daiichi Sankyo Alzheimer Product Table 80. Daiichi Sankyo Revenue in Alzheimer Business (2016-2021) & (US$ Million) Table 81. Daiichi Sankyo Recent Development Table 82. Merz Pharma Company Details Table 83. Merz Pharma Business Overview Table 84. Merz Pharma Alzheimer Product Table 85. Merz Pharma Revenue in Alzheimer Business (2016-2021) & (US$ Million) Table 86. Merz Pharma Recent Development Table 87. Pfizer Company Details Table 88. Pfizer Business Overview Table 89. Pfizer Alzheimer Product Table 90. Pfizer Revenue in Alzheimer Business (2016-2021) & (US$ Million) Table 91. Pfizer Recent Development Table 92. Johnson & Johnson Company Details Table 93. Johnson & Johnson Business Overview Table 94. Johnson & Johnson Alzheimer Product Table 95. Johnson & Johnson Revenue in Alzheimer Business (2016-2021) & (US$ Million) Table 96. Johnson & Johnson Recent Development Table 97. Lundbeck Company Details Table 98. Lundbeck Business Overview Table 99. Lundbeck Revenue in Alzheimer Business (2016-2021) & (US$ Million) Table 100. Lundbeck Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Alzheimer Market Share by Drug Type: 2020 VS 2027 Figure 2. Cholinesterase inhibitors Features Figure 3. Pipeline Drugs Features Figure 4. NMDA receptor antagonist Features Figure 5. Global Alzheimer Market Share by Application: 2020 VS 2027 Figure 6. Hospital Pharmacy Case Studies Figure 7. Retail Pharmacy Case Studies Figure 8. Online Sales Case Studies Figure 9. Alzheimer Report Years Considered Figure 10. Global Alzheimer Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Alzheimer Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Alzheimer Market Share by Regions: 2020 VS 2027 Figure 13. Global Alzheimer Market Share by Regions (2022-2027) Figure 14. Global Alzheimer Market Share by Players in 2020 Figure 15. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Alzheimer Revenue in 2020 Figure 17. Global Alzheimer Revenue Market Share by Drug Type (2016-2021) Figure 18. Global Alzheimer Revenue Market Share by Drug Type (2022-2027) Figure 19. North America Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Alzheimer Market Share by Drug Type (2016-2027) Figure 21. North America Alzheimer Market Share by Application (2016-2027) Figure 22. North America Alzheimer Market Share by Country (2016-2027) Figure 23. United States Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Alzheimer Market Share by Drug Type (2016-2027) Figure 27. Europe Alzheimer Market Share by Application (2016-2027) Figure 28. Europe Alzheimer Market Share by Country (2016-2027) Figure 29. Germany Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Alzheimer Market Share by Drug Type (2016-2027) Figure 37. Asia-Pacific Alzheimer Market Share by Application (2016-2027) Figure 38. Asia-Pacific Alzheimer Market Share by Region (2016-2027) Figure 39. China Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Alzheimer Market Share by Drug Type (2016-2027) Figure 47. Latin America Alzheimer Market Share by Application (2016-2027) Figure 48. Latin America Alzheimer Market Share by Country (2016-2027) Figure 49. Mexico Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Alzheimer Market Share by Drug Type (2016-2027) Figure 53. Middle East & Africa Alzheimer Market Share by Application (2016-2027) Figure 54. Middle East & Africa Alzheimer Market Share by Country (2016-2027) Figure 55. Turkey Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Allergan Revenue Growth Rate in Alzheimer Business (2016-2021) Figure 59. Eisai Revenue Growth Rate in Alzheimer Business (2016-2021) Figure 60. Novartis Revenue Growth Rate in Alzheimer Business (2016-2021) Figure 61. Daiichi Sankyo Revenue Growth Rate in Alzheimer Business (2016-2021) Figure 62. Merz Pharma Revenue Growth Rate in Alzheimer Business (2016-2021) Figure 63. Pfizer Revenue Growth Rate in Alzheimer Business (2016-2021) Figure 64. Johnson & Johnson Revenue Growth Rate in Alzheimer Business (2016-2021) Figure 65. Lundbeck Revenue Growth Rate in Alzheimer Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Allergan Eisai Novartis Daiichi Sankyo Merz Pharma Pfizer Johnson & Johnson Lundbeck